Cargando…

OR32-1 Endocrine Manifestations of Erdheim-Chester Disease: The Mayo Clinic Experience

Objective: Erdheim- Chester disease (ECD) is a rare form of non-Langerhans cell histiocytosis characterized by multisystem tissue infiltration of foamy histiocytes. Very few studies have investigated the prevalence of endocrine abnormalities in patients with ECD. Based on limited data, it is known t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurtado, Maria, Cortes, Tiffany, Goyal, Gaurav, Maraka, Spyridoula, O'Keeffe, Derek, Erickson, Dana, Shah, Mithun, Go, Ronald, Davidge-Pitts, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554770/ http://dx.doi.org/10.1210/js.2019-OR32-1

Ejemplares similares

Abnormal Pituitary Imaging and Associated Endocrine Dysfunctions in Erdheim-Chester Disease
por: Shekhar, Skand, et al.
Publicado: (2021)

PMON110 Panhypopituitarism as a Rare Presentation of Erdheim – Chester disease (ECD) in an Adolescent Patient
por: Menendez, Ana, et al.
Publicado: (2022)

SAT614 Clinical, Laboratory And Imaging Features Associated With Central Diabetes Insipidus (Arginine Vasopressin Deficiency) In Erdheim-Chester Disease (ECD)
por: Vaid, Sonal, et al.
Publicado: (2023)

P1049: CHARACTERISTICS AND OUTCOMES OF CARDIOVASCULAR INVOLVEMENT IN ERDHEIM-CHESTER DISEASE
por: Tawfiq, Reema, et al.
Publicado: (2023)

Arterial involvement in Erdheim–Chester disease: A retrospective cohort study
por: Villatoro-Villar, Michel, et al.
Publicado: (2018)

OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020)

ODP316 Hyponatremia as a Prognostic Factor for Mortality in COVID-19 at The National Hospital "Dos de Mayo", Lima Peru.
por: Miranda, Gonzalo, et al.
Publicado: (2022)

Endocrine Dysfunction in Covid-19
por: Das, Liza, et al.
Publicado: (2021)

Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease
por: Goyal, Gaurav, et al.
Publicado: (2017)

OR32-2 Alpha Klotho as a Marker of Disease Activity in Acromegaly
por: Schweizer, Junia, et al.
Publicado: (2019)

Tissue-Specific Tumorigenesis in Multiple Endocrine Neoplasia Type I
por: Gardiner, Juliet C
Publicado: (2021)

THU081 Differences In Circulating Microrna Levels In Genetically Confirmed Multiple Endocrine Neoplasia Type 1 And Multiple Endocrine Neoplasia Type 1 Phenocopies As Assessed By Next Generation Sequencing
por: Trukhina, Diana A, et al.
Publicado: (2023)

OR06-04 Tissue-Specific Tumorigenesis in Multiple Endocrine Neoplasia Type I
por: Gardiner, Juliet C
Publicado: (2020)

RF25 | PMON147 Plasma MicroRNA Expression in Phenocopy of Multiple Endocrine Neoplasia Type 1 Compared to Patients with Acromegaly and Primary Hyperparathyroidism: Potential Biomarkers of Multiple Endocrine Tumor Growth
por: Trukhina, Diana, et al.
Publicado: (2022)

OR32-3 Kisspeptin- a Novel Clinical Test of Hypothalamic Function in Men with Hypogonadotrophic Hypogonadism
por: Phylactou, Maria, et al.
Publicado: (2019)

SUN-LB084 The Effect Of Stimulating The Neural Response On Some Endocrine Hormones In Chicks
por: Abdulateef, Salwan, et al.
Publicado: (2019)

OR32-5 Associations between Circulation Lipocalin 2, Body Composition, and Glucose Metabolism in Active Acromegaly
por: Zhang, Yan, et al.
Publicado: (2019)

MON-453 Endocrine, Bone, and Metabolic Disorders in Adults after Allogeneic Stem-Cell Transplant
por: Demeocq, Vianney, et al.
Publicado: (2019)

SUN-489 Opioid Epidemic and Related Endocrine Effects: A Systematic Review and Meta-analysis.
por: Bruin, Mees, et al.
Publicado: (2019)

OR08-4 Endocrine Mechanisms of an Orphan G Protein-Coupled Receptor Regulating Metabolic Homeostasis
por: Ren, Hongxia
Publicado: (2022)

PMON71 Evaluation of a new transition organization for young adults with endocrine or metabolic diseases
por: Roux, Enora L, et al.
Publicado: (2022)

RF13 | PMON142 Long Non-coding RNAs in Pituitary Differentiation and Endocrine Function
por: Camper, Sally, et al.
Publicado: (2022)

SAT610 Multiple Endocrine Neoplasia Type 1 - The First Reported Case In An Indigenous Australian
por: Mignone, Edward, et al.
Publicado: (2023)

Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019)

ODP294 An Unusual Case of Endocrine Disruption as an Early Expression of Low Grade Intra Sellar Chordoma
por: Babu, Vedesh Kumar, et al.
Publicado: (2022)

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation
por: Varghese, Diana Grace, et al.
Publicado: (2022)

THU094 Multiple Endocrine Neoplasia Type 1 Tumor Recurrence After Loss To Follow Up
por: Sternlieb, Sarah Jayne, et al.
Publicado: (2023)

Differences in Menin Expression in Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1, Its Phenocopies and Sporadic Acromegaly
por: Dimitrova, Diana A, et al.
Publicado: (2021)

OR32-05 Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men
por: Maso, Ana Aulinas, et al.
Publicado: (2020)

OR32-04 Dynamic Interactions Between Luteinizing Hormone and Testosterone in Healthy Community-Dwelling Men: Impact by Age and Body Composition
por: Roelfsema, Ferdinand, et al.
Publicado: (2020)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

OR2804 Endocrine And Vision Outcomes Following (90)Yttrium Therapy For Cystic Sellar Lesions—A Prospective Cohort Study
por: MacLean, Mark A, et al.
Publicado: (2023)

SUN-295 Prevalence of Self-Reported Endocrine Comorbidities in Hypothalamic Hamartoma Patients: Data from the Hope for Hypothalamic Hamartoma Survey
por: Yuen, Kevin CJ, et al.
Publicado: (2020)

OR32-6 Pre-Surgical GH Levels Predict the Risk of Morphometric Vertebral Fracture, Which Is an Early and Frequent Event in the Natural History of Acromegaly
por: Frara, Stefano, et al.
Publicado: (2019)

MON-241 Dome Shaped Pituitary Enlargement Warrants Detailed Endocrine Evaluation Prior to Neuro-Surgical Intervention: Case Series & Analysis
por: Chakraborty, Satyam
Publicado: (2020)

MON-LB071 Panhypopituitarism Causing a Life Threatening Prolonged QT Interval Which Can Be Reversible with Treatment of Underlying Endocrine Disorders
por: Sittol, Rani, et al.
Publicado: (2019)

ODP358 The effect of multi-cultural inter-facility endocrine video case conferencing – A novel model of education during the COVID pandemic
por: Araki, Takako, et al.
Publicado: (2022)

ODP288 A Cautionary Tale of Two Endocrine Emergencies- A Patient with Pituitary Macroadenoma Presenting with Acute Adrenal Crisis Leading to Pituitary Apoplexy
por: Khalifa, Maram, et al.
Publicado: (2022)

OR32-4 Diagnostic Performance of Macimorelin vs the Insulin Tolerance Test (ITT) in 140 Patients at Varying Growth Hormone (GH) Cutpoints: A Post Hoc Analysis
por: Garcia, Jose, et al.
Publicado: (2019)

OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors
por: Galligan, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g3gjsvcl875dp867oj7rd833tq